Risk Factors for Aneurysm Rebleeding

This study is currently recruiting participants.

Verified March 2012 by Fujian Medical University

Sponsor:

Information provided by (Responsible Party):

Qingsong Lin, Fujian Medical University

ClinicalTrials.gov Identifier:

NCT01567449

First received: March 25, 2012

Last updated: March 28, 2012

Last verified: March 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

March 25, 2012

Last Updated Date

March 28, 2012

Start Date ^ICMJE

September 2011

Primary Completion Date

March 2012 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Aneurysm rebleeding [ Time Frame: up to 7 months ] [ Designated as safety issue: Yes ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT01567449 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Risk Factors for Aneurysm Rebleeding

Official Title ^ICMJE

Risk Factors in Predicting Spontaneous Intracranial Aneurysm Rebleeding During Hospitalization

Brief Summary

The purpose of this study is to examine the risk factors for aneurysm rebleeding.

Detailed Description

To investigate risk factors for spontaneous aneurysm rebleeding during hospitalization and to reach conclusions if any,of clinical signs for predicting rebleeding.

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case Control
Time Perspective: Retrospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

A total of 66 SAH patients were enrolled in this study

Condition ^ICMJE

Subarachnoid Hemorrhage, Aneurysmal

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

the case group
The case group referred to SAH patients with aneurysm rebleeding
the control group
the control group referred to SAH patients not with aneurysm rebleeding

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

Estimated Completion Date

April 2012

Primary Completion Date

March 2012 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Individual whose clinical course was clear enough to be traced back and whose conservative treatment duration was shorter than 6 weeks was included

Exclusion Criteria:

Rebleeding patients with certain inducing factors such as:
- severe emotional episode,
- severe coughing,
- constipation,
- excessive activities, or
- with coagulation disorder,or
- with other intracranial vascular malformations,such as:
  - moyamoya disease,
  - arteriovenous malformation were excluded.
Also patients who rebled while angiography were excluded.

Gender

Both

Ages

Not Provided

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: qingsong lin, master

13489991226

lqs1210305061@163.com

Location Countries ^ICMJE

China

Administrative Information

NCT Number ^ICMJE

NCT01567449

Other Study ID Numbers ^ICMJE

110011

Has Data Monitoring Committee

Yes

Responsible Party

Qingsong Lin, Fujian Medical University

Study Sponsor ^ICMJE

Fujian Medical University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Director:

Dezhi kang, professor

First Affiliated Hospital of Fujian Medical University

Information Provided By

Fujian Medical University

Verification Date

March 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top